$0.7430
0.000.00%
Pre-Market: 5:43 PM EDT
Comments
Loading...
Latest TherapeuticsMD Stock News | NASDAQ:TXMD | Benzinga
Get the latest news on TherapeuticsMD stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on TherapeuticsMD performance
Categories: All
Tuesday, November 12, 2024
Monday, August 26, 2024
Monday, August 12, 2024
Friday, May 10, 2024
Monday, March 04, 2024
Monday, February 12, 2024
Monday, December 25, 2023
Monday, November 27, 2023
Friday, November 17, 2023
Tuesday, November 14, 2023
Thursday, September 21, 2023
Thursday, August 17, 2023
Monday, August 14, 2023
Friday, June 30, 2023
Monday, June 05, 2023
Friday, January 27, 2023
Wednesday, January 18, 2023
Wednesday, January 11, 2023
Monday, January 02, 2023
Monday, December 05, 2022
Monday, November 14, 2022
Monday, October 03, 2022
Tuesday, September 27, 2022
Monday, September 12, 2022
Friday, September 09, 2022
Wednesday, September 07, 2022
Tuesday, September 06, 2022
Monday, August 15, 2022
- Snap, Gilead Sciences And Some Other Big Stocks Moving Higher On Monday
- Why Viridian Therapeutics Is Trading Higher By Around 58%, Here Are 67 Stocks Moving In Monday's Mid-Day Session
- Ten Stocks Trending on Discord for Monday August 15, 2022 Premarket: TISI, VEEE, PSTV, BBBY, HLBZ, AGFY, UBX, TXMD, VRDN, XSPA
- TherapeuticsMD shares are trading higher afte...
- Why TherapeuticsMD Stock Is Trading Higher
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- TherapeuticsMD: Q2 Earnings Insights
- TherapeuticsMD Q2 EPS $12.39 Up From $(5.41) ...
- Earnings Scheduled For August 15, 2022
Friday, August 12, 2022
Tuesday, August 02, 2022
Monday, August 01, 2022
- U.S. Stocks Turn Negative; Dow Drops Over 100 Points
- 12 Health Care Stocks Moving In Monday's Intraday Session
- This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session
- U.S. Stocks Turn Higher; Crude Oil Tumbles
- TherapeuticsMD shares are trading higher afte...
- Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial
- TherapeuticsMD Secures $15M Equity Investment...